Published on 9 May 2023 on Zacks via Yahoo Finance
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this company would post a loss of $0.09 per share when it actually produced a loss of $0.13, delivering a surprise of -44.44%.
Over the last four quarters, the company has surpassed consensus EPS estimates just once.